Healthcare
Live Price
Offline$13.49
+3.37% today
1Y Change
+235.48%
Window
Jun 27, 2025 → Jun 25, 2026
Coverage: 249 bars · Jun 27, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Corvus Pharmaceuticals, Inc. (CRVS) is a Healthcare stock with a market cap of $1.32B. The stock last traded around $13.49 and up 235.5% across the available one-year price window (Jun 27, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +81.4%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +81.4%, free cash flow -29.7% with operating margin 0.0% and ROIC -69.1%. Stock Foundry combines CRVS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CRVS
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CRVS Max Drawdown
-56.43%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CRVS and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.